1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. Canada >
  6. Quebec >
  7. Locemia Solutions - Phase III Intranasal Glucagon

Locemia Solutions - Phase III Intranasal Glucagon Overview

Life ScienceCompany

Where is Locemia Solutions - Phase III Intranasal Glucagon headquartered?

Locemia Solutions - Phase III Intranasal Glucagon is headquartered in Quebec.

What sector is Locemia Solutions - Phase III Intranasal Glucagon in?

Locemia Solutions - Phase III Intranasal Glucagon is a life science company.

Locemia Solutions - Phase III Intranasal Glucagon

Quebec
Canada,

Locemia Solutions - Phase III Intranasal Glucagon is a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon uses a proprietary glucagon nasal powder formulation that is delivered in an emergency situation using a single-use, ready-to-use device. The caregiver presses a small plunger on the bottom of the device to release the glucagon as a puff in the nose, where the glucagon is absorbed in the nasal passages.


Company Summary

SECTOR

Life Science


Try Mergr Free — See This and 220,830+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Locemia Solutions - Phase III Intranasal Glucagon

Quebec Companies , Life Science Companies , Canada Companies , Quebec Life Science Companies , Quebec Life Science with Acquisitions , Quebec Life Science with Divestitures

Related Lists for Quebec Companies

Largest Quebec Companies , Acquisitive Quebec Companies , Recently Acquired Quebec Companies , Recently Sold Quebec Companies , Private Quebec Companies , Public Quebec Companies , Acquired Quebec Companies , PE Backed Quebec Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Canada Companies

Largest Canada Companies , Acquisitive Canada Companies , Recently Acquired Canada Companies , Recently Sold Canada Companies , Private Canada Companies , Public Canada Companies , Acquired Canada Companies , PE Backed Canada Companies
Mergr

Solution for

Product

Company

Legal